ALLO — ALLOGENE THERAPEUTICS INC
Public company
InvestorLens aggregates public filing data to show which tracked investors reported holdings in this stock. Dollar values represent reported position values, not market capitalization, and may be delayed up to 45 days. Not a recommendation.
Sourced from SEC EDGAR public filings
Why are billionaires buying ALLO?
Built from public SEC filings and public economic data. Not a recommendation.
Why? — Evidence & Confidence ▾
Of 3 tracked investors who changed their ALLO position last quarter, 3 bought and 0 sold (100% buy-side). Macro conditions are a headwind for this sector (Macro Tailwind 38/100 in a Expansion regime).
- +3 tracked investors added or increased positions last quarter (Steve Cohen, Izzy Englander, Ken Griffin)
- +3 tracked investors reported holding ALLO at their latest filing
- −Current Expansion regime has historically been a headwind for this sector (Macro Tailwind 38/100)
- −13F data is disclosed up to 45 days after quarter end — positions may have changed since
- · 13F disclosure lag (up to 45 days)
- · Tracked investors are a sample, not the whole market
- · Sector regime fit is a historical average, not a guarantee
Every InvestorLens score shows its evidence — including what argues against it. Model conviction-v1 · generated 11/22/2026.
About ALLOGENE THERAPEUTICS INC (ALLO)
ALLOGENE THERAPEUTICS INC (ALLO) appears in the most recent 13F filings of 3 tracked institutional investors. The largest disclosed position is held by Ken Griffin (Citadel Advisors), valued at $40M. Across recent filings, tracked investors recorded 7 new positions, 13 increased, 3 reduced, and 4 exited. All data sourced from SEC 13F filings.
Based on recent institutional activity in ALLO
How many top investors track ALLO
A small number of top investors own this.
ALLO Ownership Composition
How ALLOGENE THERAPEUTICS INC is held across tracked investor types, based on reported 13F positions.
- Multi-Strategy / Quant100.0%
Tracked investors currently reporting ALLO
1 tracked investor has since exited this position — listed separately below.
- Ken GriffinSep 30, 2026Citadel AdvisorsShares24.7MValue$39.6M% Portfolio0.00%
- Izzy EnglanderSep 30, 2026Millennium ManagementShares5.1MValue$8.2M% Portfolio0.00%
- Steve CohenSep 30, 2026Point72 Asset ManagementShares368.5KValue$589.5K% Portfolio0.00%
Previously held ALLO
These investors reported ALLO in an earlier quarter but not in their most recent 13F. Figures below are their last reported position, not a current holding.
| Investor | Firm | Last reported shares | Value then | Last held |
|---|---|---|---|---|
| Paul Tudor Jones | Tudor Investment Corp | 72.1K | $175.9K | Mar 31, 2026 |
Recent activity
- Increased$8.2M(5.61%)Nov 16, 2026
- New$589.5KNov 16, 2026
- Increased$39.6M(141.80%)Nov 16, 2026
- Increased$722.4K(43.63%)Nov 14, 2024
- Sold$0(-100.00%)Feb 14, 2025
- $375KMay 15, 2025
- Increased$1.7M(485.06%)Aug 14, 2025
- Reduced$2.5M(-45.68%)Feb 17, 2026
- Increased$8.1M(80.42%)May 15, 2026
- Increased$10.1M(45.81%)Aug 14, 2026
- Increased$14.2M(103.18%)Nov 14, 2024
- Increased$15M(90.06%)May 15, 2025
- Increased$11.7M(0.41%)Aug 14, 2025
- Increased$17.4M(35.51%)Nov 14, 2025
- Reduced$16.7M(-12.91%)Feb 17, 2026
- Increased$21.3M(48.44%)Aug 14, 2026
- New$142.1KFeb 17, 2026
- Increased$540.1K(113.36%)May 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- Reduced$166.2K(-0.57%)Aug 14, 2024
- Sold$0(-100.00%)Nov 14, 2024
- $103.7KMay 15, 2025
- Unchanged$80.2K(0.00%)Aug 14, 2025
- Unchanged$88.1K(0.00%)Dec 9, 2025
- Increased$175.9K(1.54%)May 15, 2026
- Sold$0(-100.00%)Aug 14, 2026
- New$5.8MAug 14, 2024
- $900.6KMay 15, 2024
- $320.7KMay 15, 2024
Frequently asked questions
- How many institutional investors hold ALLO?
- 3 tracked institutional investors disclosed a position in ALLO (ALLOGENE THERAPEUTICS INC) in their most recent 13F filing.
- Who is the largest institutional holder of ALLO?
- Ken Griffin, Citadel Advisors, holds the largest disclosed position in ALLO, valued at $40M.
- Did institutional ownership of ALLO increase or decrease?
- Across recent 13F filings, tracked investors recorded 7 new positions, 13 increased, 3 reduced, and 4 fully exited ALLO.
- Where does this ALLO ownership data come from?
- SEC Form 13F-HR filings, accessed via EDGAR. 13F filings are disclosed quarterly with a 45-day reporting delay and cover U.S.-listed long equity positions only. This is not investment advice.